September 18 Sep 18
2020
8:00 AM - 9:00 AM
Friday Fri

Updates Regarding COVID-19 Advisory

In light of the University’s guidance around social distancing, we have reviewed our upcoming Pediatric Grand Rounds sessions and have decided to move forward with virtual sessions for the immediate future. 

*Please note that all Pediatric Grands Rounds sessions will be online onlyPlease do not go to LPCH Auditorium. 

Pediatric Grand Rounds Webinar (CME): Understanding the Epidemiology and Clinical Manifestations of COVID-19 in Children: An Update

Yvonne Maldonado, MD and Roshni Mathew, MD - Stanford School of Medicine

Fundamental adherence to public health practices designed to migitate infection are reasonably well-known and can be implemented both in school and the workplace. We will review what is known and where we still have knowledge gaps as we learn more about COVID-19 characteristics in children and what to expect when we return to work and school.

Fundamental adherence to public health practices designed to migitate infection are reasonably well-known and can be implemented both in school and the workplace. We will review what is known and where we still have knowledge gaps as we learn more about COVID-19 characteristics in children and what to expect when we return to work and school.

Speakers

Yvonne (Bonnie) Maldonado, MD

Professor of Pediatrics and of Epidemiology and Population Health

Chief, Division of Pediatric Infectious Diseases 

Stanford University School of Medicine 

Medical Director, Infection Prevention and Control and Attending Physician 

Lucile Packard Children's Hospital at Stanford 


Roshni Mathew, MD

Associate Medical Director, Infection Prevention & Control

Clinical Assistant Professor

Department of Pediatrics, Division of Infectious Diseases

Stanford University


Session Recording

Session Description

The SARS-CoV2 virus and related COVID-19 pandemic have resulted in shutdown of schools and workplaces throughout the world.  As the pandemic evolves infection and disease characteristics among children are still unclear, as is the risk of potential asymptomatic transmission from children to adults.  The extent of disease manifestations among children are also not well known.  However, fundamental adherence to public health practices designed to migitate infection are reasonably well-known and can be implemented both in school and the workplace.  We will review what is known and where we still have knowledge gaps as we learn more about COVID-19 characteristics in children and what to expect when we return to work and school.

Education Goals

  • Understand the epidemiology of infection with SARS-CoV2 and COVID-19 disease in children
  • Define the clinical characteristics of COVID-19 disease in children to date
  • Implement ways to measure risk of SARS-CoV2 transmission